Document Server@UHasselt >
Research publications >
Please use this identifier to cite or link to this item:
|Title: ||Case management in HCV infected people who inject drugs in Belgium|
|Authors: ||Bielen, Rob|
|Issue Date: ||2016|
|Citation: ||Belgian Week of Gastroenterology, Edition XXVII, Brussels, Belgium, 18-20/02/2016|
|Abstract: ||As you all know, Hepatitis C is still one of the leading causes of chronic liver disease, with 130-150 million people infected globally according to the WHO. The prevalence in Belgium is low in the general population, and the last consensus, based on a study of the Knowledge center in 2012, states that is estimated around 0,87% (HCV antibodies). In this study, it was also estimated that approximately 22,900 were diagnosed with HCV, with nearly 3000 new diagnoses annually.
As you can see on the figure: there is a peak in diagnosed men and women between the ages 25 and 60. This distribution can be explained by the ways of transmission, which is by blood-blood contact (eg: blood transfusions, or needle sharing in drug use). As risk-seeking behaviour is more prevalent in men, this can also explain the higher prevalence in men, and at younger age.|
|Type: ||Conference Material|
|Appears in Collections: ||Research publications|
Files in This Item:
|N/A||4.29 MB||Microsoft Powerpoint|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.